{"title":"COVID-19 Induced Hepatitis (CIH), Definition and Diagnostic Criteria of a Poorly Understood New Clinical Syndrome","authors":"E. Gadour, Zeinab E. Hassan, Khalid Shrwani","doi":"10.47690/wjghe.2020.3301","DOIUrl":null,"url":null,"abstract":"Background Covid-19 Induced Hepatitis (CIH), is a novel terminology which is used in this article for the first time in the medical literature. Objective To study the pattern of liver impairment in patients with Covid-19 as well as to find acceptable and practical diagnostic criteria of Covid-19 Induced Hepatitis (CIH). This review article gives new insight and guidance about the diagnosis of Covid-19 Induced Hepatitis (CIH), possible causes of liver damage and review of recently published data about the impairment of liver function in Covid-19 patients. Methodology Extensive literature review of newly published data and study in PubMed cited journals and other international publisher journals. Research of all studies that reviewed liver derangement in COVID-19 were mainly reviewed. Statistical analysis of submitted data were checked using SPSS. PubMed Chinese language versions were also used. Results 60% of patients with SARS can have abnormal liver functions. Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) have noticeably been abnormal in around 14–53% of patients with Covid-19 (7/114, 6.14%) (P>0.05). Impairment in liver enzymes, mainly ALT/AST, in severe Covid-19 pneumonia was significantly higher than patients with mild disease, with mean average (37.87±32.17 vs 21.22± 12.67;38.87 ± 22.55 vs 24.39± 9.79, P Conclusion Covid-19 Induced Hepatitis (CIH) is a new clinical syndrome, which can be defined as a ‘benign new transient hepatitis in a SARS-CoV-2 patients which icharacterized by the following; Gradual onset, elevated AST and ALT, Dilated sinusoids with lymphocytic infiltration of liver parenchyma, non-Obstructive jaundice, stable Underlying liver disease and no Radiological new hepatobiliary changes.’ Using GADOUR criteria may support the diagnosis, however, sensitivity and specificity are yet to be established. Meticulous statistical studies need to be done before establishing overly sensitive scoring system can be reach.","PeriodicalId":93828,"journal":{"name":"World journal of gastroenterology, hepatology and endoscopy","volume":"128 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of gastroenterology, hepatology and endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47690/wjghe.2020.3301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
Abstract
Background Covid-19 Induced Hepatitis (CIH), is a novel terminology which is used in this article for the first time in the medical literature. Objective To study the pattern of liver impairment in patients with Covid-19 as well as to find acceptable and practical diagnostic criteria of Covid-19 Induced Hepatitis (CIH). This review article gives new insight and guidance about the diagnosis of Covid-19 Induced Hepatitis (CIH), possible causes of liver damage and review of recently published data about the impairment of liver function in Covid-19 patients. Methodology Extensive literature review of newly published data and study in PubMed cited journals and other international publisher journals. Research of all studies that reviewed liver derangement in COVID-19 were mainly reviewed. Statistical analysis of submitted data were checked using SPSS. PubMed Chinese language versions were also used. Results 60% of patients with SARS can have abnormal liver functions. Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) have noticeably been abnormal in around 14–53% of patients with Covid-19 (7/114, 6.14%) (P>0.05). Impairment in liver enzymes, mainly ALT/AST, in severe Covid-19 pneumonia was significantly higher than patients with mild disease, with mean average (37.87±32.17 vs 21.22± 12.67;38.87 ± 22.55 vs 24.39± 9.79, P Conclusion Covid-19 Induced Hepatitis (CIH) is a new clinical syndrome, which can be defined as a ‘benign new transient hepatitis in a SARS-CoV-2 patients which icharacterized by the following; Gradual onset, elevated AST and ALT, Dilated sinusoids with lymphocytic infiltration of liver parenchyma, non-Obstructive jaundice, stable Underlying liver disease and no Radiological new hepatobiliary changes.’ Using GADOUR criteria may support the diagnosis, however, sensitivity and specificity are yet to be established. Meticulous statistical studies need to be done before establishing overly sensitive scoring system can be reach.
背景Covid-19诱导肝炎(CIH)是医学文献中首次使用的一个新术语。目的探讨新型冠状病毒感染(Covid-19)患者的肝损害规律,寻求可接受的、实用的新型冠状病毒性肝炎(CIH)诊断标准。这篇综述文章对Covid-19诱导肝炎(CIH)的诊断、肝损伤的可能原因以及最近发表的关于Covid-19患者肝功能损害的数据进行了综述,提供了新的见解和指导。对PubMed引用期刊和其他国际出版商期刊上新发表的数据和研究进行广泛的文献综述。主要综述了所有涉及新冠肺炎肝损害的研究。对提交的数据进行SPSS统计分析。PubMed中文版也被使用。结果60%的SARS患者可出现肝功能异常。约14 ~ 53%的新冠肺炎患者存在谷草转氨酶(AST)和丙氨酸转氨酶(ALT)异常(7/114,6.14%)(P < 0.05)。重症肺炎患者以ALT/AST为主的肝酶损害显著高于轻症患者,平均(37.87±32.17 vs 21.22±12.67;38.87±22.55 vs 24.39±9.79)P结论CIH是一种新的临床综合征,可定义为SARS-CoV-2患者的“良性新一过性肝炎”,具有以下特点;逐渐发病,AST和ALT升高,窦状窦扩张伴肝实质淋巴细胞浸润,非梗阻性黄疸,稳定的潜在肝脏疾病,无影像学上新的肝胆改变。“使用GADOUR标准可能支持诊断,然而,敏感性和特异性尚未建立。”在建立过于敏感的评分系统之前,需要进行细致的统计研究。